In yesterday’s Wall Street session, Sarepta Therapeutics Inc (NASDAQ:SRPT) shares traded at $79.97, up 8.74% from the previous session.
SRPT stock price is now -27.16% away from the 50-day moving average and -36.25% away from the 200-day moving average. The market capitalization of the company currently stands at $7.76B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $136, Deutsche Bank recently initiated with Hold rating for Sarepta Therapeutics Inc (NASDAQ: SRPT). On November 27, 2024, Needham reiterated its ‘Buy’ rating on the stock by increasing its target price from $205 to quote $202, while ‘H.C. Wainwright’ rates the stock as ‘Sell’
In other news, Nicaise Claude, Director sold 2,491 shares of the company’s stock on Mar 12 ’25. The stock was sold for $248,203 at an average price of $99.64. Upon completion of the transaction, the Director now directly owns 27,812 shares in the company, valued at $2.22 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 12 ’25, Director Nicaise Claude bought 2,491 shares of the business’s stock. A total of $248,226 was incurred on buying the stock at an average price of $99.65. A total of 6.07% of the company’s stock is owned by insiders.
During the past 12 months, Sarepta Therapeutics Inc has had a low of $73.06 and a high of $173.25. As of last week, the company has a debt-to-equity ratio of 0.88, a current ratio of 4.20, and a quick ratio of 3.18. According to the stock market information, the enterprise value for the company is $7747732992, which is based on a 33.55 price-to-earnings ratio, a 0.36 price-to-earnings-growth ratio, and a beta of 0.88. The fifty day moving average price for SRPT is $109.7868 and a two-hundred day moving average price translates $125.4508 for the stock.
The latest earnings results from Sarepta Therapeutics Inc (NASDAQ: SRPT) was released for 2024-12-31. The net profit margin was 12.37% and return on equity was 19.71% for SRPT. The company reported revenue of $658.41 million for the quarter, compared to $396.78 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 65.94 percent.
